JNK Activation in Alzheimer's Disease Is Driven by Amyloid ß and Is Associated with Tau Pathology.

Solas, Maite; Vela, Silvia; Smerdou, Cristian; Martisova, Eva; Martínez-Valbuena, Iván; Luquin, María-Rosario; Ramírez, María J

Solas, Maite; Vela, Silvia; Smerdou, Cristian; Martisova, Eva; Martínez-Valbuena, Iván; Luquin, María-Rosario; Ramírez, María J.

Afiliação

Solas M; Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Vela S; IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Smerdou C; Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain.
Martisova E; IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.
Martínez-Valbuena I; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, 31008 Pamplona, Spain.
Luquin MR; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, 31008 Pamplona, Spain.
Ramírez MJ; IdISNA, Navarra Institute for Health Research, 31008 Pamplona, Spain.

ACS Chem Neurosci ; 2023 Mar 28.

Article em En | MEDLINE | ID: mdl-36976903

Palavras-chave

Tau; beta-amyloid; cognition; hippocampus; neuroinflammation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google